PrescriptionDrugs.org

Amoxicillin vs Azithromycin

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

Amoxicillin and azithromycin (Zithromax, Z-Pack) are two of the most frequently prescribed antibiotics in the United States, used to treat a broad range of common bacterial infections [1][2]. Amoxicillin is a beta-lactam antibiotic belonging to the penicillin class, while azithromycin is a macrolide antibiotic — they have fundamentally different mechanisms of action, spectrums of activity, and clinical applications [3][5].

Amoxicillin kills bacteria by inhibiting cell wall synthesis, specifically by binding to penicillin-binding proteins (PBPs) and disrupting peptidoglycan crosslinking [1][3]. Azithromycin is bacteriostatic at typical concentrations, inhibiting bacterial protein synthesis by binding to the 50S ribosomal subunit [2][5]. These distinct mechanisms give each drug advantages against different types of infections.

The choice between amoxicillin and azithromycin depends on the specific infection being treated, local resistance patterns, patient allergies, and other individual factors [6][8]. Growing antibiotic resistance — particularly macrolide-resistant Streptococcus pneumoniae — has significantly influenced prescribing guidelines in recent years [6][7]. This comparison reviews the evidence to help patients understand why their provider may choose one over the other.

Amoxicillin vs Azithromycin: Side-by-side comparison

CategoryAmoxicillinAzithromycin
Drug ClassAminopenicillin (beta-lactam)Macrolide
MechanismInhibits cell wall synthesisInhibits protein synthesis
First-Line ForStrep throat, otitis media, sinusitisAtypical pneumonia, chlamydia, pertussis
Typical Course7-10 days (2-3 times daily)5 days (once daily) or single dose
Common Side EffectsDiarrhea, rash (esp. with mono)GI upset, QT prolongation risk
Allergy ConcernPenicillin allergy (anaphylaxis rare)Macrolide allergy (uncommon)
Generic AvailableYesYes

Efficacy: How well does each drug work?

Amoxicillin and azithromycin cover overlapping but distinct spectrums of bacteria, making each the preferred choice for different infections [1][2][3]. Amoxicillin is the first-line treatment for acute otitis media (ear infections) in children, streptococcal pharyngitis (strep throat), acute bacterial sinusitis, urinary tract infections, Helicobacter pylori eradication (in combination regimens), and dental infections [1][6][8]. It has excellent activity against Streptococcus species, Haemophilus influenzae (non-beta-lactamase producing), Enterococcus, and Listeria [1][3].

Azithromycin is first-line or a leading option for community-acquired pneumonia (particularly atypical pathogens), acute exacerbations of COPD, chlamydial infections, and traveler's diarrhea [2][6]. Its unique activity against intracellular and atypical pathogens — including Mycoplasma pneumoniae, Chlamydia pneumoniae, Chlamydia trachomatis, and Legionella — gives it a critical role in respiratory infections where these organisms are common [2][5][6].

For community-acquired pneumonia, current IDSA/ATS guidelines recommend amoxicillin as first-line for outpatient treatment when Streptococcus pneumoniae is the likely pathogen, with azithromycin added or used as monotherapy when atypical pathogen coverage is needed [6]. For strep throat, amoxicillin is clearly preferred — azithromycin is a second-line alternative reserved for patients with penicillin allergy, as macrolide resistance in Group A Streptococcus has reached 5-10% or higher in many regions [6][7].

The rise of macrolide-resistant S. pneumoniae (15-30% in the US, higher in some regions) has eroded azithromycin's utility as empiric monotherapy for pneumonia, and some guidelines now prefer doxycycline or respiratory fluoroquinolones as alternatives when macrolide resistance is a concern [6][7]. Amoxicillin resistance rates among S. pneumoniae remain much lower, generally below 2% for high-dose amoxicillin [7].

Side effects comparison

Amoxicillin is one of the best-tolerated antibiotics available. The most common adverse effects are gastrointestinal: diarrhea (5-10%), nausea (3-5%), and vomiting (1-2%) [1][3]. Amoxicillin-associated diarrhea is generally mild and resolves with completion of therapy. Allergic reactions are the primary safety concern — true penicillin allergy occurs in approximately 1-2% of the population, with manifestations ranging from rash (most common) to anaphylaxis (rare, approximately 0.01-0.05%) [1][8]. Patients with a documented penicillin allergy typically cannot receive amoxicillin, though penicillin allergy testing can identify the majority of patients who were previously labeled as allergic but can safely receive penicillins [8].

Azithromycin causes gastrointestinal side effects more frequently than amoxicillin, with diarrhea (5-14%), nausea (3-7%), and abdominal pain (3-7%) being the most common complaints [2][5]. A distinctive adverse effect of azithromycin is its potential to prolong the QTc interval, which can predispose to dangerous cardiac arrhythmias (torsades de pointes) [2][4]. A large retrospective cohort study published in the New England Journal of Medicine found that azithromycin was associated with a small but statistically significant increase in cardiovascular death compared to amoxicillin (hazard ratio 2.88, 95% CI 1.79-4.63 for the highest-risk patients) [4].

This cardiac risk is most relevant for patients with existing QTc prolongation, hypokalemia, hypomagnesemia, or those taking other QTc-prolonging medications [2][4]. For low-risk patients, the absolute risk increase is very small. Hepatotoxicity is uncommon with both drugs but has been reported more frequently with azithromycin, particularly cholestatic hepatitis [2]. Both can cause Clostridioides difficile-associated diarrhea, though the risk is generally considered lower with azithromycin due to its minimal disruption of anaerobic gut flora [5].

Cost comparison

Both amoxicillin and azithromycin are available as inexpensive generics. Generic amoxicillin capsules (500 mg, typically prescribed as 500 mg three times daily for 10 days) cost approximately $4-$10 for a full treatment course [10]. It is one of the most affordable antibiotics available and is included on virtually every pharmacy's discount generic list.

Generic azithromycin (Z-Pack: 250 mg x 6 tablets, taken as 500 mg on day 1 then 250 mg on days 2-5) typically costs $8-$15 for the complete 5-day course [10]. While slightly more expensive than amoxicillin, it remains very affordable. Extended courses (e.g., 500 mg daily for 3 days) are similarly priced.

Both are universally covered by insurance plans with no prior authorization requirements. The total cost of a treatment course is comparable enough that cost should not be the primary factor in choosing between them. However, for long-term or prophylactic use (e.g., azithromycin for COPD exacerbation prevention), azithromycin costs may be higher on a monthly basis.

Convenience and dosing

Azithromycin has a significant convenience advantage in its dosing regimen. The standard Z-Pack course is 5 days total (500 mg day 1, then 250 mg days 2-5), and many infections can be treated with a 3-day course (500 mg daily for 3 days) [2]. For chlamydial infections, a single 1-gram dose of azithromycin is effective, making it one of the simplest antibiotic regimens available [2]. This convenience promotes adherence, which is a genuine clinical benefit.

Amoxicillin typically requires 7-10 day courses dosed two to three times daily (e.g., 500 mg three times daily or 875 mg twice daily), which is less convenient [1][6]. Patient adherence to 10-day amoxicillin courses for strep throat is notoriously poor, with many patients stopping after feeling better in 3-4 days, potentially contributing to treatment failure and resistance development.

Amoxicillin is available in capsules, chewable tablets, and oral suspension (multiple flavors), making it very flexible for pediatric dosing [1]. Azithromycin comes in tablets, oral suspension, and single-dose packets [2]. Both can be taken with or without food, though azithromycin absorption may be slightly better on an empty stomach in some formulations [2]. Neither requires refrigeration in tablet form, though suspensions have different storage requirements [1][2].

Which is right for you?

The choice between amoxicillin and azithromycin should be driven primarily by the specific infection being treated and guided by current evidence-based guidelines [6][8]. They are not interchangeable — each is clearly preferred for different clinical scenarios.

Amoxicillin is the right choice for strep throat (first-line per IDSA guidelines), acute otitis media, acute bacterial sinusitis, urinary tract infections, and dental infections [1][6][8]. Its narrow spectrum, excellent tolerability, and low resistance rates for its target organisms make it the superior option for these common infections. It is also safe in pregnancy (FDA Category B) and is one of the most commonly prescribed antibiotics for pregnant women [1].

Azithromycin is preferred for atypical pneumonia (Mycoplasma, Chlamydia pneumoniae, Legionella), chlamydial genital infections, pertussis (whooping cough), and is commonly used for COPD exacerbations and traveler's diarrhea [2][6]. Its shorter course duration and once-daily dosing make it particularly useful when adherence to a longer amoxicillin course is a concern. It is the standard alternative for penicillin-allergic patients who need treatment for strep throat or other infections where amoxicillin would otherwise be first-line [6][8].

Patients with known penicillin allergy should not receive amoxicillin without prior allergy evaluation [8]. Patients with cardiac risk factors (long QT syndrome, electrolyte abnormalities, medications that prolong QTc) should use azithromycin cautiously and may need cardiac monitoring [4]. Always complete the full prescribed course of whichever antibiotic is chosen, even if symptoms improve before the medication is finished. Discuss any questions about your antibiotic selection with your healthcare provider.

Frequently asked questions

References

  1. [Regulatory] FDA. Amoxicillin capsules prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050542s032lbl.pdf Accessed 2025-01-15.
  2. [Regulatory] FDA. Zithromax (azithromycin) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050710s039,050711s036,050784s023lbl.pdf Accessed 2025-01-15.
  3. [Clinical] Andes D, Craig WA. Animal model pharmacokinetics and pharmacodynamics: a critical review. Int J Antimicrob Agents. 2002;19(4):261-268. https://pubmed.ncbi.nlm.nih.gov/15356224/ Accessed 2025-01-15.
  4. [Regulatory] Ray WA, et al. Azithromycin and the risk of cardiovascular death. N Engl J Med. 2012;366(20):1881-1890. https://pubmed.ncbi.nlm.nih.gov/22571202/ Accessed 2025-01-15.
  5. [Clinical] Zhanel GG, et al. The macrolides. Expert Opin Pharmacother. 2001;2(5):875-893. https://pubmed.ncbi.nlm.nih.gov/14657456/ Accessed 2025-01-15.
  6. [Regulatory] Metlay JP, et al. Diagnosis and Treatment of Adults with Community-Acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45-e67. https://pubmed.ncbi.nlm.nih.gov/31573350/ Accessed 2025-01-15.
  7. [Regulatory] CDC. Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services, CDC. https://pubmed.ncbi.nlm.nih.gov/31553411/ Accessed 2025-01-15.
  8. [Regulatory] Shulman ST, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the IDSA. Clin Infect Dis. 2012;55(10):e86-e102. https://pubmed.ncbi.nlm.nih.gov/23091044/ Accessed 2025-01-15.
  9. [Regulatory] CDC. Antibiotic Use and Resistance. https://www.cdc.gov/antibiotic-use/index.html Accessed 2025-01-15.
  10. [Observational] GoodRx. Current prescription drug pricing data. https://www.goodrx.com/ Accessed 2025-01-15.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: